概述
-
货号
PAD12601
-
宿主
Rabbit -
同种型
IgG -
克隆类型
Polyclonal -
免疫原
Ranibizumab -
经测试应用
ELISA: 1:4000-1:8000 -
靶标
Rabbit polyclonal to Lucentis. -
特异性
The product is specific for Ranibizumab. This antibody serves as an excellent positive control for Ranibizumab immunogenicity (ADA) assays. -
浓度
0.5 mg/ml -
纯化方式
Purified by antigen affinity column. -
Accession号
CAS: 347396-82-1 -
应用
ELISA -
状态
Liquid -
保存溶液
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. -
稳定性和存储
The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. -
背景
Ranibizumab with trade name Lucentis, is an FDA-approved drug for the treatment of patients with neovascular (Wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO). It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment. Ranibizumab binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity. Antibodysystem Anti-Ranibizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ranibizumab.
图片
参考文献
评价